IVW-1001 Phase 1/2 in Subjects With Dry Eye Disease

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Dry Eye Disease

In brief

Double-masked, dose-response, trial of IVW-1001 in subjects with dry eye disease.

Key facts

Study ID

NCT06400459

Run by

IVIEW Therapeutics Inc.

People needed

150

Starts

2024-06-25

Expected to finish

2024-10-15

Last updated by the study team

2026-02-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects of any gender at least 18 years of age at the Screening Visit
• Able to voluntarily provide written informed consent to participate in the study
• Able and willing to comply with all study procedures and restrictions, follow study instructions, and complete required study visits
• Diagnosis of Dry Eye Disease (DED)

You may not qualify if…

• Corneal fluorescein staining score of 4 using the NEI grading system
• Intraocular pressure ≥23 mmHg
• History of glaucoma or ocular hypertension in either eye requiring past or current medical or surgical intervention
• Subjects with ocular inflammatory conditions (eg, conjunctivitis, keratitis, severe anterior blepharitis, etc.) not related to DED

Where it is running

• Houston Eye Associates — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.